Cerebyx Coupons & Savings Card – Discount Prices from $18.27

When using Cerebyx, it's important to be aware of several safety considerations:

Cardiovascular Risks with Rapid Infusion: Administering Cerebyx intravenously too quickly can lead to serious heart-related issues, such as severe low blood pressure and irregular heartbeats. To minimize these risks, the infusion rate should not exceed 150 mg of phenytoin sodium equivalents per minute in adults and 2 mg per kilogram per minute (or 150 mg per minute, whichever is slower) in children. Continuous heart monitoring is recommended during and after the infusion.

Potential for Serious Skin Reactions: Some individuals may experience severe skin reactions, including conditions like Stevens-Johnson syndrome and toxic epidermal necrolysis. If a rash develops, it's crucial to contact a healthcare provider immediately.

Risk of Multiorgan Hypersensitivity Reactions: Cerebyx can cause a serious condition known as Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS), which affects multiple organs. Symptoms may include fever, rash, swollen lymph nodes, and inflammation of internal organs. Immediate medical attention is necessary if these symptoms occur.

Angioedema Alert: Swelling of the face, lips, or throat, known as angioedema, can occur and may be life-threatening. If any swelling is noticed, discontinue use and seek emergency medical care.

Hematopoietic Complications: Cerebyx may lead to blood-related issues, such as a decrease in blood cell counts. Regular blood tests are advised to monitor for these potential problems.

Local Injection Site Reactions: There have been reports of "purple glove syndrome," characterized by swelling, discoloration, and pain at the injection site. This condition may develop days after the injection and requires medical evaluation.

Considerations for Patients with Liver or Kidney Issues: Individuals with liver or kidney impairments, or those with low albumin levels, may have higher levels of unbound phenytoin in their blood. Monitoring unbound phenytoin levels is important in these cases to avoid toxicity.

Use During Pregnancy: Cerebyx can harm an unborn baby if used during pregnancy, potentially leading to birth defects and other developmental issues. Women who are pregnant or planning to become pregnant should discuss alternative treatments with their healthcare provider.

Hyperglycemia Risk: Cerebyx may cause elevated blood sugar levels. Patients with diabetes should monitor their blood glucose closely while on this medication.

Withdrawal Seizures: Abruptly stopping Cerebyx can trigger seizures. Any changes to the dosage should be made under the guidance of a healthcare professional.

Being informed about these risks and maintaining open communication with your healthcare provider can help ensure the safe use of Cerebyx.

When taking Cerebyx (fosphenytoin), it's important to be aware of potential interactions with other medications, supplements, and substances, as these can affect how Cerebyx works or increase the risk of side effects.

Medications That Can Increase Phenytoin Levels:

Some drugs may raise the levels of phenytoin (the active form of Cerebyx) in your blood, potentially leading to toxicity. These include:

• Antiepileptic drugs: Ethosuximide, Felbamate, Oxcarbazepine, Methsuximide, Topiramate.
• Antifungal agents: Fluconazole, Ketoconazole, Itraconazole, Miconazole, Voriconazole.
• Antidepressants: Fluoxetine, Fluvoxamine, Sertraline.
• Gastric acid reducers: Cimetidine, Omeprazole.
• Sulfonamide antibiotics: Sulfamethizole, sulfaphenazole, Sulfadiazine, Sulfamethoxazole-Trimethoprim.
• Other medications: Amiodarone, Chloramphenicol, Disulfiram, estrogen, Isoniazid, Methylphenidate, phenothiazines, salicylates, ticlopidine, Tolbutamide, Trazodone, Warfarin.

Medications That Can Decrease Phenytoin Levels:

Other drugs may lower phenytoin levels, reducing its effectiveness. These include:

• Antineoplastic agents: Bleomycin, carboplatin, Cisplatin, doxorubicin, Methotrexate.
• Antiviral agents: Fosamprenavir, nelfinavir, Ritonavir.
• Antiepileptic drugs: Carbamazepine, Vigabatrin.
• Other substances: Chronic alcohol use, Diazepam, Diazoxide, Folic Acid, reserpine, Rifampin, St. John's wort, Theophylline.

Medications Affected by Phenytoin:

Phenytoin can also influence the effectiveness of other medications by decreasing their levels, such as:

• Anticoagulants: Apixaban, Dabigatran, edoxaban, Rivaroxaban.
• Antiepileptic drugs: Carbamazepine, felbamate, lamotrigine, topiramate, oxcarbazepine, Lacosamide.
• Antiplatelet agents: Ticagrelor.
• Cholesterol-lowering drugs: Atorvastatin, Fluvastatin, Simvastatin.
• Antiviral agents: Efavirenz, lopinavir/ritonavir, indinavir, nelfinavir, ritonavir, saquinavir.
• Calcium channel blockers: Nifedipine, Nimodipine, nisoldipine, Verapamil.
• Other medications: Albendazole, chlorpropamide, Clozapine, Cyclosporine, Digoxin, disopyramide, folic acid, methadone, Mexiletine, Praziquantel, Quetiapine.

Alcohol and Cerebyx:

Consuming alcohol while on Cerebyx can alter phenytoin levels, leading to either increased side effects or reduced seizure control. It's advisable to avoid or limit alcohol intake during treatment.

Herbal Supplements:

Certain herbal products can interact with Cerebyx. For example, St. John's wort may decrease phenytoin levels, reducing its effectiveness. Always inform your healthcare provider about any herbal supplements you're taking.

Monitoring and Consultation:

Due to these potential interactions, it's crucial to:

• Inform your healthcare provider about all medications, supplements, and substances you are using.
• Regularly monitor phenytoin blood levels as directed by your doctor.
• Report any unusual symptoms or side effects promptly.

By staying informed and maintaining open communication with your healthcare team, you can help ensure the safe and effective use of Cerebyx in your treatment plan.